Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy

Journal of Heart and Lung Transplantation

Volumn 34, Issue 12, 2015, Pages 1535-1541

  Stulak, John M ^a   Dunlay, Shannon M ^a   Sharma, Shashank ^a   Haglund, Nicholas A ^b   Davis, Mary Beth ^b   Cowger, Jennifer ^c   Shah, Palak ^d   Masood, Faraz ^e   Aaronson, Keith D ^e   Pagani, Francis D ^e   Maltais, Simon ^a  

^a Mayo Clinic   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c ST VINCENT HOSPITAL   (United States)

^d INOVA FAIRFAX HOSPITAL   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

anti coagulation; device exchange; HeartWare; lytic therapy; pump thrombosis; thrombus; ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; THROMBUS; VENTRICULAR ASSIST DEVICE; ADOLESCENT; ADVERSE EFFECTS; CLINICAL TRIAL; HEART ASSIST DEVICE; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; REMISSION; RETROSPECTIVE STUDY; THROMBOSIS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; THROMBOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84949817077     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.10.020     Document Type: Article

References (19)

1. J.K. Kirklin, D.C. Naftel, R.L. Kormos, and et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device J Heart Lung Transplant 33 2014 12 22
2. M.S. Slaughter, F.D. Pagani, E.C. McGee, and et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
3. S.S. Najjar, M.S. Slaughter, F.D. Pagani, and et al. An analysis of pump thrombosis events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol J Heart Lung Transplant 33 2014 23 34
4. F.D. Pagani, C.A. Milano, A.J. Tatooles, and et al. HeartWare HVAD for the treatment of patients with advanced heart failure ineligible for cardiac transplantation: results of the ENDURANCE Destination Therapy trial [abstract] J Heart Lung Transplant 34 4 Suppl 2015 S9
5. U.P. Jorde, K.D. Aaronson, S.S. Najjar, and et al. A quantitative analysis of pump parameters in the HeartWare left ventricular assist device system for the identification and management of pump thrombus Circulation 130 2014 A18677
6. J.M. Stulak, D. Lee, J.W. Haft, and et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device J Heart Lung Transplant 33 2014 60 64
7. D.J. Goldstein, R. John, C. Salerno, and et al. Algorithm for the diagnosis and management of suspected pump thrombus J Heart Lung Transplant 32 2013 667 670
8. J.A. Cowger, M.A. Romano, P. Shah, and et al. Hemolysis: A harbinger of adverse outcome after left ventricular assist device implant J Heart Lung Transplant 2014 33 2014 35 43
9. R.C. Starling, N. Moazami, S.C. Silvestry, and et al. Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
10. M.S. Slaughter, Y. Naka, R. John, and et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy J Heart Lung Transplant 29 2010 616 624
11. K. Schlendorf, C.B. Patel, T. Gehrig, and et al. Thrombolytic therapy for thrombosis of continuous flow ventricular assists devices J Card Fail 20 2014 91 97
12. M. Al-Quthami, R. Jumean, Kociol, and et al. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis Circ Heart Failure 5 2012 e68 e70
13. J.R. Tellor, S.M. Smith, S.M. Prasad, and et al. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices J Heart Lung Transplant 33 2014 94 101
14. A. Kamouth, R. John, and P. Eckman Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics Ann Thorac Surg 94 2012 281 283
15. P. Lenneman, S. Combs, K. Rhode, and et al. Management and outcomes of ventricular assist device patients with suspected pump thrombosis J Heart Lung Transplant 32 2013 S186 S187
16. H. Ota, H. Yerebakan, Akashi, and et al. Continuous-flow left ventricular assist device exchange: clinical outcomes J Heart Lung Transplant 33 2014 65 70
17. N. Moazami, C.A. Milano, R. John, and et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality Ann Thorac Surg 95 2013 500 505
18. J.M. Stulak, J. Cowger, H.W. Haft, M.A. Romano, K.D. Aaronson, and F.D. Pagani Device exchange after primary left ventricular assist device implantation Ann Thorac Surg 95 2013 1262 1267
19. S.V. Rojas, M. Avsar, Z. Khalpey, J.S. Hanke, A. Haverich, and J.D. Schmitto Minimally-invasive off-pump left ventricular assist device exchange: anterolateral thoracotomy Artif Organs 38 2014 539 542